Keros Therapeutics Inc (KROS) — Cash Flow Reinvestment Rate
Keros Therapeutics Inc (KROS) has a Cash Flow Reinvestment Rate of 0.08x as of September 2025, reinvesting $264.00K (capex $132.00K plus investments $-132.00K) from operating cash flow of $3.25 Million. Check KROS cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Keros Therapeutics Inc Cash Flow Reinvestment Rate (2018–2018)
Historical reinvestment intensity for Keros Therapeutics Inc across 1 annual periods. Explore how well can Keros Therapeutics Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Keros Therapeutics Inc (2018–2018)
Year-by-year capital reinvestment analysis for Keros Therapeutics Inc. For live market cap and broader valuation context, see KROS market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2018 | 0.06x | $434.00K | $7.04 Million | $217.00K | — |